
Even the best doctors are overwhelmed by the 20,000 known diseases – understandably so. At best, they are familiar with the symptoms of around 1,000 illnesses, so the correct diagnosis is not an easy undertaking. However, incorrect or late diagnoses can have life-threatening consequences for patients. If the right diagnosis were made in time, 1.5 million lives could be saved every year.
Symptoma has taken on this problem. The company based in Attersee, Salzburg, and Vienna has developed an intelligent database for doctors and is researching solutions to optimize the diagnosis process.
Medical information via chatbot
Fifteen years of research and development have gone into Symptoma’s AI software algorithms. According to CEO Jama Nateqi, it is one of the world’s largest disease databases. Numerous doctors use the AI, but patients can also access it. The use is simple: “Users enter symptoms. Our chatbot then automatically asks the right questions to better narrow down the possible cause or search. This works so well now that you can enter ‘Tiramisu’ as a search term, and the system will ask you about stomach pain and suggest salmonella as a possible cause.” Ten million doctors and patients worldwide rely on Symptoma every month to research the causes of symptoms.
AI helps with Covid-19 risk detection
At the start of the COVID-19 pandemic, Symptoma adapted its symptom checker accordingly and trained the AI on COVID-19 symptoms. Users only need to answer the chatbot’s questions and enter their symptoms. The symptom checker then indicates the likelihood of being infected with COVID-19 based on the symptoms. If desired, a COVID-19 test can also be arranged right away.
The company has thus developed the first AI worldwide that calculates personal COVID-19 risk and has also been certified as a medical device. Symptoma has been validated in several scientific studies (such as in Nature and JMIR) and tested in over 100 million tests worldwide in 36 different languages. One study demonstrated that Symptoma has the highest accuracy on the market for symptomatic COVID-19 cases, with a hit rate of 96.32%, making it more reliable than solutions from Apple or the Center for Disease Control in the US, for example.
In November 2020, Symptoma also started a cooperation with the city of Vienna. Right from the start, the symptom checker specifically for Vienna citizens processed a proud 1.5 million questions and answers within 24 hours. The digital option for assessing personal COVID-19 risk was well received by the Viennese. Symptoma, or rather its CEO Jama Nateqi, also achieved another success: He was recently voted Austrian of the Year 2020 in the research category by the newspaper “Die Presse”.
This might also interest you
12. March 2026
SALZ 2026: Innovation and Technology in Focus – Startups, AI and Future Markets in Salzburg
The SALZ – Festival for Innovation & Technology brought together companies, startups, research institutions and public stakeholders at Messe Salzburg on 11 March 2026. With keynotes, panels, matchmaking and startup pitches, the event provided a platform for emerging technology trends, new collaborations and exchange within the innovation ecosystem.
18. February 2026
SALZ 2026: A Festival for Innovation
How can companies remain competitive, innovative, and resilient in challenging times? SALZ – Festival for Innovation & Technology, together with the startup and investment conference SALT’N’VENTURE, will provide concrete answers on March 11, 2026, at Messezentrum Salzburg, bringing together industry, startups, and investors.
16. February 2026
Kick-off for the Salzburg Innovation Award
The WIKARUS – Salzburg Business Award will be presented every two years in the future. In the intervening years, the Salzburg Innovation Award will be announced, launching for the first time in 2026.
11. November 2025
Eleven Million Euros for Five New Research Centers
Salzburg is investing in research: around eleven million euros from EU and state funds will go toward establishing five new research and transfer centers. They cover key future-oriented topics: artificial intelligence, climate protection, health, tourism, and data security.